Agenda
Day 1
Tuesday, November 3, 2026
10:30AM-11:30AM: Pre-Conference workshop
10:30-11:30AM —Designing for Approval and Adoption: Aligning Evidence, Regulation, and Market Access Early (RSVP required)
Joseph Ferrara, Chief Strategy Officer, Veranex
Pablo Morales, Chief Medical Officer, Veranex
11:30-12:00PM: Registration and working box lunch – Presidential Ballroom Foyer
12:10-12:15PM: Welcome Address
Stephen Levin, Editor-in-Chief, MedTech Strategist and Market Pathways
12:15-1:15PM: Keynote: On-Ramps to FDA: A Session with CDRH Director Michelle Tarver
Hear what’s happening at FDA’s device center—direct from the source. CDRH Director Michelle Tarver will join us for the opening keynote and fireside chat to discuss the growing number of ways innovative startups can engage with the agency, and how they can help facilitate the path to market access and adoption. We’ll discuss hot topics like TAP, early feasibility studies, FDA-CMS alignment, AI, cybersecurity, and much more. Bring your questions.
Michelle Tarver, MD, PhD, Director, Center for Devices and Radiological Health, US Food and Drug Administration
David Filmore, Executive Editor, Market Pathways (moderator)
1:20-1:25PM: Moderator- Lynn Carney, Director, Agency and Alliances, Medmarc
1:25-1:35PM: Navigation Sciences (NCI SBIR Investor Initiatives)
1:35-1:45PM: CoreMedic
1:45-1:55PM: Neuwire Medical
1:55-2:05PM: OtoNexus Medical Technologies
2:05-2:15PM: Cerevia Neurosciences
2:15-2:25PM: Lite Run
2:25-2:45PM Networking Break – Presidential Ballroom Foyer
2:45-3:10PM: Anatomy of a Deal: Johnson & Johnson/Atraverse—J&J’s CV Comeback Continues
Stephen Levin, Editor-in-Chief, MedTech Strategist and Market Pathways (moderator)
3:10-3:15PM: Sponsor Moderator - Chris Rupp, Vice President of Commercialization, Avio Medtech
3:15-3:25PM: Implant Preservation Devices
3:25-3:35PM: IMVARIA (NCI SBIR Investor Initiatives)
3:35-3:45PM: Cordance Medical (NCI SBIR Investor Initiatives)
3:45-3:55PM: Inmedix
3:55-4:05PM: Cipher Surgical
4:10-5:00PM: Pulsed Field Ablation: From the Lab to Market Disruption
Dan Kaiser, DVP, Product Development and Engineering, Electrophysiology, Abbott
David Neale, CEO, Arga Medtech
Brad Sutton, Chief Medical Officer, Boston Scientific
Tushar Sharma, Americas Chief Medical and Scientific Officer, Electrophysiology, Johnson & Johnson
Mark Turco, CEO, Field Medical
Reed Miller, Senior Writer/Market Analyst, Medtech Strategist (moderator)
5:00-5:05PM: Moderator - CBSET
5:05-6:05PM: MedTech Innovator Execution Competition
Paul Grand, CEO, MedTech Innovator (Host)
Swathi Ravi, Director, Exploration, Edwards Lifesciences (Judge)
Abigail Hunter-Syed, Head of Olympus Innovation Ventures, Olympus Ventures (Judge)
6:05-7:30PM: Networking Reception - Presidential Ballroom Foyer
Day 2
Wednesday, November 4, 2026
8:00-8:30AM: Registration & Continental Breakfast - Presidential Ballroom Foyer
8:35-8:45AM: Spotlight: MedTech Strategist
Reed Miller, Senior Writer/Market Analyst, Medtech Strategist
8:45-9:25AM: Funding the Next Breakthrough: What's Changed—and What Hasn't in Early-Stage Deals
Susana Amorim, Investment Manager - Healthtech Venture & Growth, Gilde Healthcare
Sarah Fox, Senior Associate, Angelini Ventures
Auriel August, Principal, Sante
Ruben Osnabrugge, Partner, 415 Capital
Tracy Warren, Sr Managing Director, Go Red for Women Fund, American Heart Association Ventures
9:30-9:35AM: Moderator – Michael Groosman, Director of Sales, Rev.1 Engineering
9:35-9:45AM: Stratus Medical
9:45-9:55AM: MenHealth
9:55-10:05AM: Lumicell (NCI SBIR Investor Initiatives)
10:05-10:15AM: Healionics
10:15-10:35AM: Networking Break -- Presidential Ballroom Foyer
10:35-11:15AM: You Built It. Will Strategics Buy It?
Virginia Giddings, Vice President Exploration, Edwards Lifesciences
Bruce Rosengard, Vice President and Global Lead for External Innovation, Johnson & Johnson MedTech
Roshan Vora, Partner, McKinsey & Company (moderator)
11:15-11:20AM: Moderator - Dan Purvis, CEO & Founder, Velentium Medical
11:20-11:30AM: ANEUVO
11:30-11:40AM: Tympanogen
11:40-11:50AM: Sofusa
11:50-12:00PM: Memoire Medical
12:00-12:40PM: Is Your Company IP-Ready? Preparing for Investment, Partnerships, and Acquisition
12:40-1:50PM: Lunch – Bivouac Room
1:55-2:35PM: Anatomy of a Deal: Medtronic/CathWorks—Using AI to Advance CV Diagnosis
Chris Eso, Senior Vice President, Global Head, Corporate and Business Development & Ventures, Medtronic
Peter Fitzgerald, Professor of Medicine and Engineering Director, Center for Cardiovascular Innovation, Stanford University Medical Center, and Co-founder/Managing Partner, Triventures
Andra Jones, VP, Business Development, Strategy, and Integration, Interventional Cardiology Therapies, Medtronic
Ramin Mousavi, Founder, Chairman & CEO, NovoMed Partners
Stephen Levin, Editor-in-Chief, MedTech Strategist and Market Pathways (moderator)
2:35-2:40PM: Sponsor Moderator - Chris Bolton, Partner, Greenberg Traurig
2:40-2:50PM: Secure Closure
2:50-3:00PM: BlackLight Surgical
3:00-3:10PM: Perimeter Medical
3:10-3:20PM: Rivanna Guidance Solutions
3:20-3:40PM: Networking Break -- Presidential Ballroom Foyer
3:40-4:20PM: Corporate Venture as a Strategic Growth Engine in MedTech
Terri Burke, Senior Partner, Intuitive Ventures
Imran Hamid, Senior Director, Venture Investments, LivaNova
Abigail Hunter-Syed, Head of Olympus Innovation Ventures, Olympus Ventures
Yuji Yokomizo, Director, Terumo Ventures
Biren Mehta, Vice President, Venture Investments – MedTech at Johnson & Johnson Development Corporation (JJDC)
David Filmore, Executive Editor, Market Pathways (moderator)
4:20-5:00PM: Start-up Lifelines: How Incubators Accelerate MedTech Innovation
Eb Bright, President, ExploraMed
Hanson Gifford, Managing Partner, The Foundry
Howard Levin, Managing Partner and Chief Medical Officer, Coridea
Amr Salahieh, President & CEO, Shifamed
Hal Stowe, Director, Regulatory Affairs, Eurofins
Stephen Levin, Editor-in-Chief, MedTech Strategist and Market Pathways (moderator)
5:00-5:40PM: When to replace the Founding CEO
Megan MacDonagh, Vice President, Medtech, Ally Bridge Group
Josh Makower, MD, The Yock Family Professor, Professor of Medicine and of Bioengineering; Stanford University Schools of Medicine and Engineering, The Byers Family Director and Co-Founder, Stanford Mussallem Center for Biodesign
Scott Huennekens, Principal, Front Foot Ventures
Roger Brooks, President & CEO, RBrooks Group (moderator)
5:40-6:40PM: MedTech Innovator Finals Competition - Mid-Stage Startups
Imran Hamid, Senior Director, Venture Investments, LivaNova (Judge)
Paul Grand, CEO, MedTech Innovator (Host)
6:40-8:00PM: Reception: Presidential Ballroom Foyer
Day 3
Thursday, November 5, 2026
8:15-8:35AM: Continental Breakfast - Presidential Ballroom Foyer
8:35-8:45AM: Spotlight: Market Pathways
David Filmore, Executive Editor, Market Pathways (moderator)
8:50-9:25AM: The Corporate Development Roundtable: How Medtech Leaders Evaluate M&A, Investments and Strategic Partnerships
Justin Castelli, Vice President, New Business Development, Boston Scientific Corporation
Chris Eso, Senior Vice President, Global Head, Corporate and Business Development & Ventures, Medtronic
Nate Harrington, Managing Partner, Philips Ventures
Reed Miller, Senior Writer/Market Analyst, Medtech Strategist (moderator)
9:25-9:30AM: Moderator - CBSET
9:30-9:40AM: EBAMed
9:40-9:50AM: GrOwnValve
9:50-10:00AM: Byonyks
10:00-10:10AM: Ropana Vascular
10:10-10:20AM: Ruth Medical
10:20-10:40AM: Networking Break – Presidential Ballroom Foyer
10:40-11:20AM: AI as a Strategic Differentiator in Medical Devices
Jennifer Bayon, VP, Strategic Growth & Business Development, Vektor Medical
Filip Peters, CEO, Acorai
Bibi Sattar Marques, Partner, Buenavista Equity Partners
Reed Miller, Senior Writer/Market Analyst, Medtech Strategist (moderator)
11:20-12:00PM: Deals, Dollars & Disruption: Navigating the Medtech M&A and Investment Landscape
Jed Cohen, Managing Director, Medical Technology Investment Banking, Raymond James
Jon Norris, Managing Director, HSBC
Mark Secrest, Managing Director, Healthcare Investment Banking, U.S. Bancorp l BTIG
Stephen Levin, Editor-in-Chief, MedTech Strategist and Market Pathways (moderator)
12:00-12:40PM: The De-Risking Race: Why Capital Is Moving to Late-Stage Medtech
William Dai, Founding Managing Partner, ShangBay Capital
Chris Murray, Principal, MVM Partners
Phil Oettinger, Partner, Wilson Sonini (moderator)
12:40-1:20PM: Singapore Rising: From Promise to MedTech Powerhouse
Mike Carusi, Managing Partner, Lightstone Ventures
Andrew Cleeland, CEO, Fogarty Innovation
Benjamin Teo, Lead Product Development / Deputy Director, AStar- Agency for Science Technology Research
Stephen Levin, Editor-in-Chief, MedTech Strategist and Market Pathways (moderator)
1:20PM: Box Lunch - Presidential Ballroom Foyer
